4.6 Article

Comprehensive analysis of ferritin subunits expression and positive correlations with tumor-associated macrophages and T regulatory cells infiltration in most solid tumors

Journal

AGING-US
Volume 13, Issue 8, Pages 11491-11506

Publisher

IMPACT JOURNALS LLC
DOI: 10.18632/aging.202841

Keywords

ferritin light chain; ferritin heavy chain; tumor-associated macrophages; T regulatory cells; iron metabolism

Funding

  1. National Natural Science Foundation of China (NSFC) [81870696, 81670902, 81972527]
  2. Guangdong Natural Science Foundation of China [2018B030312008, 2018A030313667, 2016A030310167]
  3. Guangzhou Science and Technology Project of China [201704020098, 201605030003]

Ask authors/readers for more resources

The study found different expression regulation of FTL and FTH1 in various human cancers, which were associated with patient prognosis and tumor-infiltrating immune cells, suggesting their important role in regulating tumor immunity to solid cancers.
Ferritin is the most important iron storage form and is known to influence tumor immunity. We previously showed that expression of ferritin light chain (FTL) and ferritin heavy chain (FTH1) subunits is increased in head and neck squamous cell carcinoma (HNSC). Here, we analyzed solid tumor datasets from The Cancer Genome Atlas and Genotype-Tissue Expression databases to investigate correlations between FTL and FTH1 expressions and (i) patient survival, using univariate, multivariate, Kaplan-Meier and Receiver Operator Characteristic analysis; and (ii) tumor-infiltrating immune cell subsets, using the bioinformatics tools Estimation of Stomal and Immune cells in Malignant Tumor tissues, Microenvironment Cell Population-counter, Tumor Immune Estimation Resource, and Tumor Immunology Miner. We found that FTL and FTH1 are upregulated and downregulated, respectively, in most of the human cancers analyzed. Tumor FTL levels were associated with prognosis in patients with lower grade glioma (LGG), whereas FTH1 levels were associated with prognosis in patients with liver hepatocellular carcinoma, HNSC, LGG, and kidney renal papillary cell carcinoma. In many cancers, FTL and FTH1 levels was significantly positively correlated with tumor infiltration by tumor-associated macrophages and T regulatory cells. These results suggest an important role for FTL and FTH1 in regulating tumor immunity to solid cancers.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Pathology

Calpeptin attenuates cigarette smoke-induced pulmonary inflammation via suppressing calpain/IκBα signaling in mice and BEAS-2B cells

Jingjing Zuo, Zhangwei Hu, Tao Liu, Chen Chen, Zezhang Tao, Shiming Chen, Fen Li

PATHOLOGY RESEARCH AND PRACTICE (2018)

Article Oncology

Ferritin: A potential serum marker for lymph node metastasis in head and neck squamous cell carcinoma

Zhangwei Hu, Lei Wang, Yong Han, Fen Li, Anyuan Zheng, Yong Xu, Fei Wang, Bokui Xiao, Chen Chen, Zezhang Tao

ONCOLOGY LETTERS (2019)

Article Cell Biology

Ferroptosis Driver SOCS1 and Suppressor FTH1 Independently Correlate With M1 and M2 Macrophage Infiltration in Head and Neck Squamous Cell Carcinoma

Zhang-Wei Hu, Yi-Hui Wen, Ren-Qiang Ma, Lin Chen, Xue-Lan Zeng, Wei-Ping Wen, Wei Sun

Summary: The study identified the ferroptosis driver SOCS1 and suppressor FTH1 as independent prognostic factors in head and neck squamous cell carcinoma, correlating with M1 and M2 macrophage infiltration. Targeting ferroptosis-immunomodulation may enhance immunotherapy efficacy.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Immunology

CD69 and SBK1 as potential predictors of responses to PD-1/PD-L1 blockade cancer immunotherapy in lung cancer and melanoma

Zhang-Wei Hu, Wei Sun, Yi-Hui Wen, Ren-Qiang Ma, Lin Chen, Wen-Qing Chen, Wen-Bin Lei, Wei-Ping Wen

Summary: CD69 and SBK1 are potential biomarkers to predict response to cancer immunotherapy, guiding treatment decisions for precision therapy.

FRONTIERS IN IMMUNOLOGY (2022)

No Data Available